Postpartum Depression: Pathophysiology, Treatment, and Emerging Therapeutics

2019/01/27 by Donna E. Stewart, Simone N. Vigod · 2 citations
Medicine · Psychology · #Maternal Mental Health During Pregnancy and Postpartum #Child and Adolescent Psychosocial and Emotional Development #Infant Development and Preterm Care

paper · doi:10.1146/annurev-med-041217-011106

Abstract

Postpartum depression (PPD) is common, disabling, and treatable. The strongest risk factor is a history of mood or anxiety disorder, especially having active symptoms during pregnancy. As PPD is one of the most common complications of childbirth, it is vital to identify best treatments for optimal maternal, infant, and family outcomes. New understanding of PPD pathophysiology and emerging therapeutics offer the potential for new ways to add to current medications, somatic treatments, and evidence-based psychotherapy. The benefits and potential harms of treatment, including during breastfeeding, are presented.

Citations

• Detection of Postnatal Depression

Cited by

• Time for united action on depression: a Lancet–World Psychiatric Association Commission
• Maternal separation: Does it hold the potential to model consequences of postpartum depression?
• Detecting and explaining postpartum depression in real-time with generative artificial intelligence

Related

• Growth and Physiological Development During Adolescence
• Postpartum Depression is a Family Affair: Addressing the Impact on Mothers, Fathers, and Children
• Prevalence and incidence of postpartum depression and environmental factors: the IGEDEPP cohort
• Redesigned community postpartum care to prevent and treat postpartum depression in women – a one‐year follow‐up study
• Incidence of Postpartum Depression and Its Association With Antenatal Psychiatric Symptoms: A Longitudinal Study in 25 Villages of Rural South Karnataka